ArticleBMC pulmonary medicine2026

Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance.

Taylor Caton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.